Looking into the safety of AAV vectors.
Kay
Mark A
MA
Nakai
Hiroyuki
H
D000818:Animals; D000229:Dependovirus / Q000235:genetics* / Q000472:pathogenicity; D015316:Genetic Therapy / Q000009:adverse effects*; D005822:Genetic Vectors / Q000009:adverse effects* / Q000235:genetics*; D006801:Humans; D007938:Leukemia / Q000209:etiology / Q000235:genetics; D051379:Mice; D016254:Mutagenesis, Insertional; D012190:Retroviridae / Q000235:genetics; D018570:Risk Assessment; D012449:Safety; D016511:Severe Combined Immunodeficiency / Q000235:genetics / Q000628:therapy; D016662:Virus Integration / Q000235:genetics